Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Non-small-cell lunG Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Study completedNCT05348668
What this trial is testing

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Anhui Provincial Hospital 78
Testing effectiveness (Phase 2)Study completedNCT04364620
What this trial is testing

AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

Who this might be right for
NSCLC Stage IV
Alethia Biotherapeutics 35
Testing effectiveness (Phase 2)Study completedNCT00006004
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00217698
What this trial is testing

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 63
Early research (Phase 1)Study completedNCT01839955
What this trial is testing

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Neelesh Sharma MD PhD 12
Early research (Phase 1)Study completedNCT00162318
What this trial is testing

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 30
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Not applicableStudy completedNCT02409108
What this trial is testing

Perfusion-Induced Hyperthermia for Metastatic Carcinoma

Who this might be right for
Metastatic Non-Small Cell Lung CarcinomaSolid Tumor, Adult
Jonathan Kiev 4
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Early research (Phase 1)Ended earlyNCT02974725
What this trial is testing

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Who this might be right for
Non-Small Cell Lung CancerMelanoma
Novartis Pharmaceuticals 241
Large-scale testing (Phase 3)Study completedNCT00961415
What this trial is testing

AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 376
Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Large-scale testing (Phase 3)Study completedNCT00003117
What this trial is testing

Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 584
Testing effectiveness (Phase 2)Study completedNCT01109524
What this trial is testing

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsCarcinomaCancer of the Lung+1 more
Eli Lilly and Company 72
Early research (Phase 1)UnknownNCT06127940
What this trial is testing

K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Karolinska University Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02453282
What this trial is testing

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Carcinoma NSCLC
AstraZeneca 1,118
Not applicableUnknownNCT06496360
What this trial is testing

Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Qilu Hospital of Shandong University 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04487080
What this trial is testing

Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 1,074
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Next Page